BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12100582)

  • 1. Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis.
    Millar BC; Moore JE; Xu J; Walker MJ; Hedderwick S; McMullan R
    Lett Appl Microbiol; 2002; 35(2):102-6. PubMed ID: 12100582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.
    Tamura M; Watanabe K; Mikami Y; Yazawa K; Nishimura K
    J Clin Microbiol; 2001 Dec; 39(12):4309-15. PubMed ID: 11724837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
    McCullough MJ; Clemons KV; Stevens DA
    J Clin Microbiol; 1999 Feb; 37(2):417-21. PubMed ID: 9889231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness.
    Karahan ZC; Güriz H; Ağirbaşli H; Balaban N; Göçmen JS; Aysev D; Akar N
    Mycoses; 2004 Dec; 47(11-12):465-9. PubMed ID: 15601450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of Candida albicans isolates from clinical specimens.
    Gurbuz M; Kaleli I
    Mycopathologia; 2010 Apr; 169(4):261-7. PubMed ID: 20012366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping of Candida albicans and Candida dubliniensis by 25S rDNA analysis shows association with virulence attributes in oral candidiasis.
    Tantivitayakul P; Panpradit N; Maudcheingka T; Klaophimai A; Lapirattanakul J
    Arch Oral Biol; 2019 Jan; 97():18-24. PubMed ID: 30321765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis Malaysia.
    Tay ST; Chai HC; Na SL; Ng KP
    Mycopathologia; 2005 Apr; 159(3):325-9. PubMed ID: 15883714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron.
    Boucher H; Mercure S; Montplaisir S; Lemay G
    Gene; 1996 Nov; 180(1-2):189-96. PubMed ID: 8973366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CARE-2-negative Candida albicans isolates as Candida dubliniensis.
    Morschhäuser J; Ruhnke M; Michel S; Hacker J
    Mycoses; 1999 Apr; 42(1-2):29-32. PubMed ID: 10394844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
    Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
    Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [25S intron analysis followed by restriction enzyme digestion performed for genotyping Candida albicans isolates].
    Karahan ZC; Saran B; Yenice S; Ağırbaşlı H; Arıkan Akan O; Tekeli A
    Mikrobiyol Bul; 2012 Apr; 46(2):257-65. PubMed ID: 22639314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and distribution of group I intron genotypes of Candida albicans colonising critically ill patients.
    Millar BC; Xu J; McMullan R; Walker MJ; Hedderwick S; Moore JE
    Br J Biomed Sci; 2005; 62(1):24-7. PubMed ID: 15816208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis].
    Mesa LM; Arcaya N; Cañas O; Machado Y; Calvo B
    Rev Iberoam Micol; 2004 Sep; 21(3):135-8. PubMed ID: 15709787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans or Candida dubliniensis?
    Ells R; Kock JL; Pohl CH
    Mycoses; 2011 Jan; 54(1):1-16. PubMed ID: 19682314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence and antifungal susceptibility of microsatellite genotypes of Candida albicans from superficial and deep locations.
    Wang M; Cao Y; Xia M; Al-Hatmi AMS; Ou W; Wang Y; Sibirny AA; Zhao L; Zou C; Liao W; Bai F; Zhi X; de Hoog S; Kang Y
    Yeast; 2019 May; 36(5):363-373. PubMed ID: 31037772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genotypic detection of Candida albicans and Candida dubliniensis strains isolated from oral mucosa of AIDS pediatric patients.
    Livério HO; Ruiz LDS; Freitas RS; Nishikaku A; Souza AC; Paula CR; Domaneschi C
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e14. PubMed ID: 28423089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
    Momani OM; Qaddoomi A
    East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Candida africana and Candida dubliniensis, in vulvovaginal candidiasis: First Turkish Candida africana isolates from vulvovaginal candidiasis.
    Hazirolan G; Altun HU; Gumral R; Gursoy NC; Otlu B; Sancak B
    J Mycol Med; 2017 Sep; 27(3):376-381. PubMed ID: 28641919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.
    McManus BA; Coleman DC; Moran G; Pinjon E; Diogo D; Bougnoux ME; Borecká-Melkusova S; Bujdákova H; Murphy P; d'Enfert C; Sullivan DJ
    J Clin Microbiol; 2008 Feb; 46(2):652-64. PubMed ID: 18057125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.